Novartis receives FDA approval for Afinitor Disperz to treat subependymal giant cell

[News]

The U.S. Food and Drug Administration today approved Afinitor Disperz (everolimus tablets for oral suspension), a new pediatric dosage form of the anti-cancer drug Afinitor (everolimus) used to treat a rare brain tumor called subependymal giant cell astrocytoma.

More... (http://www.news-medical.net/news/20120830/Novartis-receives-FDA-approval-for-Afinitor-Disperz-to-treat-subependymal-giant-cell-astrocytoma.aspx)